Preliminary results from a phase II trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutationsA. L. Ho,Nicole G. Chau,J. Bauman,K. Bible,A. Chintakuntlawar,Maria E. Cabanillas,Deborah Jean Lee Wong,I Braña Garcia,Marcia S. Brose,V. Boni,C. Even, M. Razaq,V. Mishra, K. Bracken, D. Wages,C. Scholz,A. GualbertoANNALS OF ONCOLOGY(2018)引用 33|浏览69暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要